What Spondylosis Actually Is and Where Autoimmune Confusion Comes In
Spondylosis is wear and tear on the spinal discs and facet joints. It shows up on X-rays as osteophytes, disc space narrowing, and sclerosis. Most people over 50 have some degree of it and many never know because the findings don't match symptoms. The confusion starts when someone with neck or back pain gets told they have an autoimmune problem. Spondylosis itself isn't autoimmune. It's mechanical degeneration. But there's a condition called ankylosing spondylitis that is autoimmune and it affects the spine too. People mix them up constantly in clinic. I ran into this exact problem with a patient last year. A 58-year-old came in with chronic neck pain and stiffness. X-rays showed moderate cervical spondylosis at C5-C6 and C6-C7. His inflammatory markers were normal. ESR and CRP were fine. He had no morning stiffness longer than 30 minutes. He didn't have enthesitis or dactylitis anywhere else. The imaging looked like textbook degenerative changes. But he was convinced something autoimmune was going on because his father had ankylosing spondylitis. We ordered HLA-B27 testing anyway. It came back negative. The diagnosis stayed spondylosis with cervical radiculopathy. The takeaway was that family history alone doesn't push you toward an autoimmune workup. The clinical picture does. The key distinction comes down to three things. Age of onset, inflammatory markers, and imaging pattern. Degenerative spondylosis typically starts after 40. Ankylosing spondylitis usually starts before 45, often in the 20s. Inflammatory markers are normal in spondylosis unless there's acute nerve root irritation causing secondary inflammation. In axial spondyloarthritis, CRP is elevated in about 60% of active cases. ESR is less sensitive but can be useful. Imaging shows osteophytes and disc degeneration in spondylosis. In ankylosing spondylitis you see sacroiliitis first, then syndesmophytes that look different from osteophytes. Syndesmophytes are thin and vertical along the disc margin. Osteophytes are broad and horizontal bridging the vertebral body.
Here's the counter-intuitive part that most people miss. You can have spondylosis and an autoimmune disease at the same time. I had a patient with confirmed ankylosing spondylitis who also developed degenerative changes from altered biomechanics due to spinal stiffness. The degenerative changes weren't causing the primary symptoms. The active inflammatory disease was. If you blame all the pain on spondylosis in that scenario, you under treat the autoimmune component. Conversely, if you assume every spine finding is autoimmune, you overinvestigate and expose patients to unnecessary radiation and cost. The balance matters. Seronegative spondyloarthropathies complicate the picture further. Psoriatic arthritis can cause spinal involvement without a psoriasis history in about 15% of cases. The skin findings sometimes appear after joint symptoms. I learned this the hard way with a patient who had bilateral sacroiliitis on MRI and elevated CRP. No skin lesions anywhere. I missed the diagnosis for eight months until he mentioned a childhood rash that resolved on its own. Re-examining the scalp and nail beds revealed subtle psoriatic changes. The lesson is to look harder before you rule out seronegative disease. Nail pitting, subtle plaques behind the ears, and inverse lesions in skin folds are easy to miss. Imaging protocols matter a lot here. Plain X-rays miss early sacroiliitis. MRI with STIR sequences detects bone marrow edema in the sacroiliac joints before structural damage appears. If you suspect axial spondyloarthritis and X-rays are negative, don't stop. Get an MRI. The sensitivity of X-ray for early sacroiliitis is roughly 40%. MRI sensitivity is over 90%. That gap is why patients bounce between specialists for years before getting a correct diagnosis.
Treatment differs fundamentally between the two conditions. Spondylosis responds to mechanical interventions. Physical therapy focusing on cervical or lumbar stabilization, traction for radiculopathy, epidural steroid injections for acute nerve root inflammation. Surgery is reserved for progressive neurological deficit or intractable pain with structural compression. Ankylosing spondylitis responds to immunomodulation. NSAIDs are first line. If those fail, biologics targeting TNF-alpha or IL-17 show meaningful improvement in about 60-70% of patients. Methotrexate doesn't help axial disease. I've seen it prescribed repeatedly for axial symptoms where it has zero evidence base. It works for peripheral arthritis in spondyloarthritis but not the spine. The downside of biologic therapy is infection risk. TNF inhibitors increase the risk of tuberculosis reactivation by roughly three to four times. You need screening with interferon-gamma release assay or PPD before starting. Hepatitis B reactivation is another real concern. I had a patient who developed fulminant hepatitis B while on adalimumab because we only checked surface antigen and missed occult infection. Now we order hepatitis B panel including core antibody before every biologic initiation. The extra cost is minimal compared to the alternative. Another limitation nobody talks about is that imaging findings don't always correlate with symptoms. I've seen patients with severe spondylosis on MRI who function normally. I've also seen patients with mild degenerative changes having debilitating pain. The structure-function relationship in the spine is weak. This is why treatment decisions should be clinical, not purely radiological. Don't operate on a scan. Operate on a patient with matching neurological deficits and failed conservative management.
Get the Full Details
For people wanting to understand their own imaging reports, here's a practical framework. Look for the words osteophyte, disc space narrowing, vacuum phenomenon, and facet arthropathy. Those point toward degenerative spondylosis. Look for sacroiliitis, syndesmophyte, bamboo spine, and enthesitis. Those point toward inflammatory spondyloarthropathy. The presence of both patterns on the same study happens. It means you need a rheumatology referral rather than trying to sort it out independently. Diagnostic criteria exist but they're imperfect. The ASAS classification criteria for axial spondyloarthritis require either HLA-B27 positivity with two other features or active sacroiliitis on imaging with two other features. The other features include inflammatory back pain, response to NSAIDs, enthesitis, uveitis, psoriasis, diarrhea, good response to TNF inhibitors, elevated CRP, and family history. The criteria are designed for research, not for clinical certainty. A patient can meet criteria and still have seronegative disease that evolves differently than textbook cases. Lab testing has its own limitations. HLA-B27 is present in about 90% of ankylosing spondylitis patients but also in 4-8% of the general population depending on ethnicity. A positive test doesn't diagnose anything by itself. It's a risk marker. About 1% of HLA-B27 positive individuals develop axial spondyloarthritis over their lifetime. The negative predictive value is decent but the positive predictive value is poor without clinical correlation.
CRP is the more useful marker for monitoring disease activity in confirmed cases. ESR is slower to change and less reliable in elderly patients where baseline values creep up with age regardless of inflammation. I track CRP in my spondyloarthritis patients every 3-6 months during biologic therapy. It's not perfect but it catches flares earlier than symptoms alone in about 30% of cases. Physical therapy approaches differ too. For spondylosis, McKenzie method exercises and cervical lordosis restoration can help discogenic and facet-mediated pain. For ankylosing spondylitis, the priority is maintaining spinal mobility and chest expansion. Flexion deformities are the main functional threat. Posterior chain stretching and extension exercises prevent the stooped posture that becomes irreversible once fusion completes. I've lost patients to progressive kyphosis because they stopped physical therapy after symptom improvement on biologics. Maintenance matters regardless of treatment response. Surgery for spondylosis typically involves discectomy, foraminotomy, or decompression with or without fusion. The success rate for radiculopathy relief is about 80-85%. Success rate for axial neck or back pain without radiculopathy drops to 50-60%. Patient selection is everything. If the pain is mechanical and matches the imaging, surgery has a reasonable chance. If the pain is diffuse with central sensitization or comorbid depression, surgical outcomes deteriorate significantly. Screening for psychological comorbidities before spine surgery isn't optional. It's standard of care that most surgeons follow inconsistently.
Surgery for ankylosing spondylitis is rare and high-risk. Osteotomies for severe kyphotic deformity carry complications rates of 30-50% in published series. These aren't routine procedures. They require specialized centers with experience. A patient I consulted for had a 3-level cervical fusion attempted at a community hospital. The case converted to open with significant blood loss and postoperative complications. The deformity was better managed with a single high-cervical osteotomy at a referral center. Geography matters for complex cases. The overlap syndrome between degenerative and inflammatory spine disease deserves more attention. Elderly patients with long-standing ankylosing spondylitis develop superimposed spondylosis from altered spinal mechanics. The fused segments transfer stress to adjacent mobile levels. This produces combined degenerative and inflammatory symptoms that confuse both patients and clinicians. The treatment requires balancing immunosuppression for the active autoimmune component with mechanical interventions for the degenerative component. There's no single algorithm. Each case needs individualized assessment. If you're reading your own imaging and wondering which category you fall into, the safest approach is to bring the images and reports to a rheumatologist if you're under 50 with morning stiffness and elevated inflammatory markers. If you're over 50 with mechanical pain and normal labs, a spine specialist or physiatrist is the right starting point. Self-diagnosis based on internet searches leads to either unnecessary anxiety or dangerous delay in treatment. The overlap in symptoms is real. The distinction matters for management.
